COMP members
The European Medicines Agency (EMA) publishes details of the members of its Committee for Orphan Medicinal Products (COMP).
Human
Rare diseases
The COMP consists of:
All members serve on the committee for a renewable three year period.
In accordance with the committee rules of procedures, observers from non-EEA authorities with whom there is a confidentiality arrangement may attend the plenary meetings on regular basis. Attendance is reflected in the committee minutes as from 2024.
The list includes each member's:
For more information on EMA's policy on handling competing interests for committee members, see Handling competing interests.
For contact details, please refer to the affiliated organisations of individual committee members.
Members nominated by the Member States
Members nominated by the European Commission on the EMA's recommendation
Members representing patients' organisations nominated by the European Commission
Awaiting Nomination.
Awaiting Nomination.
Awaiting Nomination.
Awaiting Nomination.